Results 91 to 100 of about 81,848 (246)
A specific radioimmunoassay for androstenedione with reduced bridge-binding [PDF]
, 1984 Antibody used in a steroid radioimmunoassay raised against a steroid hapten-carrier protein conjugate may recognize both the hapten and the chemical bridge to the protein.
Counsell, Raymond E. +2 more
core +1 more source
Narcolepsy and rapid eye movement sleep
Journal of Sleep Research, Volume 34, Issue 2, April 2025.Summary Since the first description of narcolepsy at the end of the 19th Century, great progress has been made. The disease is nowadays distinguished as narcolepsy type 1 and type 2. In the 1960s, the discovery of rapid eye movement sleep at sleep onset led to improved understanding of core sleep‐related disease symptoms of the disease (excessive ...
Francesco Biscarini +4 more
wiley +1 more source
Radioimmunoassay of ursodeoxycholic acid in serum.
Journal of Lipid Research, 1978 A sensitivie and specific radioimmunoassay for the measurement of serum ursodeoxycholic acid has been developed. Ursodeoxycholic acid bound to bovine serum albumin was used as an antigen, and antiserum to this antigen was raised in the rabbit.
I Makino +4 more
doaj +1 more source
Serum immunoreactive erythropoietin of children in health and disease [PDF]
, 1990 Serum immunoreactive erythropoietin (siEPO) was determined in cord serum from neonates (n = 97, gestational age 36-43 weeks), in healthy children from birth to adolescence (n = 260) and in children with haematological (n = 30), renal (n = 10) and ...
Pohlandt, F. +5 more
core +1 more source
COVID‐19–Induced Narcolepsy Type I With Cataplexy: A Short Report
Journal of Sleep Research, EarlyView.ABSTRACT Narcolepsy type I is a rare neurological sleep disorder characterised by chronic excessive daytime sleepiness, cataplexy, and low orexin (hypocretin) levels. Infection with SARS‐CoV‐2 has been linked to neurological and neuropsychiatric sequelae, but cases of post‐COVID narcolepsy remain extremely uncommon.
Torsten Vinding Merinder +2 more
wiley +1 more source
Radioimmunoassay of human plasma Lp(a) lipoprotein
Journal of Lipid Research, 1977 A quantitative immunodiffusion assay demonstrated Lp(a) lipoprotein in 91% (911 of 1000) of subjects. In order to quantitate Lp(a) in all plasma, a sensitive and specific double antibody radioimmunoassay was developed.
J J Albers, J L Adolphson, W R Hazzard
doaj +1 more source
Journal of Sleep Research, EarlyView.ABSTRACT Narcolepsy is classified as type 1 (NT1) or type 2 (NT2) mainly according to hypocretin deficiency rather than cataplexy. While CRH neuron loss in the PVN has been described in NT1, it remains unclear whether similar changes occur in narcolepsy without cataplexy.
Ling Shan +5 more
wiley +1 more source
Radioimmunoassay of Endothelin in Human Plasma
, 1993 Biokemi, endothelin, radioimmunoassay, human ...
Hedner, Thomas +6 more
core +1 more source
Improved Glucagon Sensitivity Following Weight Loss: A Systematic Review and Meta‐Analysis
Obesity Reviews, EarlyView.ABSTRACT Objective This systematic review and meta‐analysis investigated the effect of weight loss in people with obesity on two biomarkers of glucagon resistance: fasting plasma glucagon and alanine. Methods A comprehensive search was conducted in Medline and Embase. Random‐effects meta‐analyses and correlation analyses were performed.
Hye‐Rin Charlotte Kim +4 more
wiley +1 more source
A sensitive radioimmunoassay for isepentenyladenosine
, 1977 A sensitive radioimmunoassay for the nucleoside isopentenyladenosine (iA) by using iA-specific antibodies and a nitrocellulose membrane filtration technique is described.
Humayun, M. Z. +5 more
core +2 more sources